Furthermore, in an AD mouse model (AppNLGF), Nrf2 activation in glial cells helped suppress pro-inflammatory responses and inhibited phagocytic activation, thereby reducing astrocyte proliferation, mitigating neuronal damage around amyloid plaques, increasing glutathione levels, and improving cognitive function [27,28]. This evidence concerns the gene NFE2L2 and Alzheimer disease.